Validity and Reliability of the L Test in Geriatric Individuals
Investigating the Validity and Reliability of the L Test in Geriatric Individuals
1 other identifier
observational
70
1 country
1
Brief Summary
Age-related declines in mobility, gait speed, balance, and functional independence are major determinants of morbidity and fall risk among older adults. Widely used functional mobility assessments-such as the Timed Up and Go Test (TUG) and the 10-Meter Walk Test (10MWT)-provide valuable information but do not fully capture the multidimensional motor tasks required in daily life, such as turning, directional changes, sit-to-stand transitions, and combined mobility tasks. The L Test, originally developed as an expanded form of TUG, includes turning, curved-path walking and a longer walking distance, and may therefore offer a more comprehensive assessment of functional mobility. Although previous studies have demonstrated high test-retest reliability and significant correlations with TUG in clinical populations such as Parkinson's disease and chronic conditions, evidence regarding the reliability and validity of the L Test in healthy geriatric individuals is lacking. This study aims to address this gap by evaluating the psychometric properties of the L Test in older adults. Purpose: The purposes of the study are to: Evaluate the test-retest reliability of the L Test in geriatric individuals. Determine its concurrent validity by examining relationships with TUG and 10MWT. Calculate measurement error indices including Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC). Hypotheses H1: The L Test is a valid assessment tool for older adults. H2: The L Test demonstrates acceptable test-retest reliability (ICC ≥ 0.70). H3: The L Test shows a strong correlation with TUG (r ≥ 0.50). H4: The L Test shows a strong correlation with 10MWT (r ≥ 0.50). Study Design: A cross-sectional methodological study with repeated measures (test-retest) one week apart. Participants: Target population: Adults aged ≥65 years who can independently ambulate at least 10 meters. Sample size: 58 participants based on power analysis; increased to 70 to compensate for potential attrition. Sampling: Simple random sampling. Inclusion Criteria: ≥65 years of age Mini-Mental State Examination ≥24 Able to walk 10 meters independently Voluntary participation Exclusion Criteria: Lower limb surgery within the past 6 months Diagnosed cardiovascular, neurological, or pulmonary disease Visual or auditory impairments affecting test safety Procedures Participants will complete: L Test, Timed Up and Go Test (TUG), 10-Meter Walk Test (10MWT; normal and fast speed). One week later, all assessments will be repeated under the same conditions. Outcome Measures: Primary: L Test time (seconds) Secondary:TUG time, 10MWT time (normal and fast pace), SEM and MDC values. Pearson correlation with TUG and 10MWT Statistical Analysis: Test-retest reliability: ICC Concurrent validity: Pearson correlation coefficient Measurement error: SEM, MDC Significance level: p \< 0.05 Ethical Considerations: All tests conducted by trained physiotherapists. Continuous supervision to minimize fall risk. Written informed consent obtained. Participants may withdraw at any time. Confidentiality ensured Expected Outcomes: The study is expected to: Provide normative data for the L Test in the geriatric population Demonstrate the test's psychometric robustness Support the clinical use of the L Test for functional mobility screening Contribute to physiotherapy and geriatric rehabilitation literature
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 22, 2025
CompletedFirst Submitted
Initial submission to the registry
November 29, 2025
CompletedFirst Posted
Study publicly available on registry
December 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2026
CompletedDecember 11, 2025
November 1, 2025
5 months
November 29, 2025
November 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
L Test Procedure
Starting seated in a standard chair. Standing up upon instruction. Walking 3 m straight. Turning left and walking 7 m. Returning via the same route. Sitting down again. Total distance: 20 m. Time recorded using a stopwatch. The L-test has far less well-established normative data and validated cut-offs for older adults than TUG or gait speed. Several recent reviews note a lack of age-specific reference values or consensus study-based cut-off scores for older community-dwelling adults. Because of this limited evidence base, the L-test is useful for within-person change (reliability, MDC) but less suitable for population screening using a single universal cut-off.
one week
Secondary Outcomes (2)
Time Up and Go (TUG) Test
one week
10 Metre Walking Test (10 MWT)
one week
Study Arms (1)
Geriatric Individuals
≥65 years Able to understand instructions Able to walk independently (with or without minimal assistive device) MMSE ≥24 (Mini Mental State Examination) No acute medical condition
Eligibility Criteria
As explained in the section on inclusion criteria: ≥65 years, able to understand instructions, able to walk independently (with or without minimal assistive device), MMSE (Mini Mental State Examination) ≥24, no acute medical condition
You may qualify if:
- ≥65 years
- Able to understand instructions
- Able to walk independently (with or without minimal assistive device)
- MMSE (Mini Mental State Examination) ≥24
- No acute medical condition
You may not qualify if:
- Lower-limb surgery within 6 months
- Diagnosed neurological or cardiopulmonary disease
- Visual or auditory impairments preventing safe assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasan Kalyoncu University Medical Research and Application Center
Gaziantep, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
November 29, 2025
First Posted
December 11, 2025
Study Start
October 22, 2025
Primary Completion
March 21, 2026
Study Completion
April 21, 2026
Last Updated
December 11, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Data are not shared due to ethical principles. Should your work be published as a scientific paper, the data may be available from the relevant publication. Data may also be shared upon request for inclusion in a meta-analysis or systematic review study.